Emergent BioSolutions | EBS - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 8.73B 2.85B 2026-06
Alnylam Pharmaceuticals USD 22.44B 10.57B 2026-10
Amarin USD 290M 51M 2025-12
ANI Pharmaceuticals USD 1.88B 133M 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Coherus Biosciences USD 172M 19M 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Exelixis USD 18.9B 4.43B 2026-10
Glaxosmithkline GBP 109.29B 9.36B 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Lonza CHF 39.68B 980.61M 2025-06
Merck USD 370.6B 12.1B 2026-10
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Pacira USD 1.69B 695M 2026-10
Pfizer USD 138.44B 15.37B 2026-06
PTC Therapeutics USD 4.94B 1.86B 2026-10
Sanofi EUR 99.83B 8.68B 2026-10
Sarepta Therapeutics USD 1.9B 388M 2026-06
United Therapeutics USD 23B 2.19B 2026-06
Vanda Pharmaceuticals USD 279M 6M 2024-12